Clinical Trials Logo

Hypoxia clinical trials

View clinical trials related to Hypoxia.

Filter by:

NCT ID: NCT04005911 Recruiting - Hypoxia Clinical Trials

Non-Contact Respiratory Rate Monitoring

Start date: April 18, 2019
Phase:
Study type: Observational

The purpose of this study is to compare thermographic estimates of respiratory rate to manual counting (visual inspection) and thoracic impedance-based methods. Thermographic methods rely on detection of temperature changes in the nose and mouth that occur as room temperature air passes through the nose and mouth during ventilation, and may offer a non-invasive means of measuring respiratory rate without requiring any patient contact.

NCT ID: NCT04001023 Recruiting - Clinical trials for Fallopian Tube Cancer

Overcoming Chemoresistance in Advanced Ovarian Cancer Via Targeting Hypoxia

OVANOX
Start date: March 9, 2017
Phase: N/A
Study type: Interventional

The goal of this non-randomized prospective study is to use 18F-EF5-PET/CT imaging to identify and locate intraabdominal hypoxic ovarian cancer lesions. With targeted surgical sampling, precisely obtain hypoxic and potentially chemoresistant cancer tissue for our analyses and identify key molecular differences between hypoxic and non-hypoxic tumors within the same patient. A portion of advanced stage EOC are inoperable at diagnosis and can be treated with neoadjuvant chemotherapy (NACT) before surgery. This approach offers a unique opportunity to study how hypoxic tumor areas respond to treatment.

NCT ID: NCT03969615 Recruiting - Clinical trials for Acute Respiratory Failure

SuperNO2VA™ and General Anesthesia Postoperative Care

Start date: October 15, 2018
Phase: N/A
Study type: Interventional

The purpose of the study is to randomly and prospectively evaluate the differences in outcomes between the control group (closed full facemask immediate post-extubation with standard oxygenating device used post-operatively in PACU) and the SuperNO2VA™ group (SuperNO2VA™ immediate post-extubation and post-operatively in PACU)

NCT ID: NCT03949049 Recruiting - Neonatal Hypoxia Clinical Trials

Citicoline as Neuroprotector in Neonates Exposed to Hypoxia

Start date: February 1, 2019
Phase: Phase 3
Study type: Interventional

Citicoline as neuroprotector in neonates exposed to hypoxia: A randomized controlled trial

NCT ID: NCT03922802 Recruiting - Clinical trials for Spinal Cord Injuries

SCI Acute Intermittent Hypoxia and Non-Invasive Spinal Stimulation Combined With Gait Training

Start date: December 1, 2020
Phase: N/A
Study type: Interventional

This is a single blind, sham controlled crossover trial that will evaluate the effectiveness of acute intermittent hypoxia therapy (AIH) combined with transcutaneous (non-invasive) spinal cord stimulation on gait and balance function for individuals after spinal cord injury.

NCT ID: NCT03907904 Recruiting - Clinical trials for Brain Hypoxia Ischemia

Continuous, Non-invasive Monitoring of Intraoperative Cerebral Perfusion and Oxidative Metabolism (CPOM)

Start date: July 1, 2019
Phase:
Study type: Observational

This study uses a CPOM Optical neuromonitor to assess the relationship between brain cytochrome C oxidase, cerebral oxygen saturation and blood pressure during surgery performed under general anesthesia.

NCT ID: NCT03835741 Recruiting - COPD Exacerbation Clinical Trials

Automated Adjustment of Oxygen on Patient With Acute COPD Exacerbation - FreeO2 HypHop

FreeO2 HypHop
Start date: December 17, 2018
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate if automated adjustment of oxygen (with FreeO2 device) can reduce the hospital length of stay for acute exacerbation of COPD with comparison of manual oxygen titration.

NCT ID: NCT03806816 Recruiting - Clinical trials for Hypoxic-Ischemic Encephalopathy

Use of Melatonin for Neuroprotection in Asphyxiated Newborns

MELPRO
Start date: December 13, 2018
Phase: N/A
Study type: Interventional

Protection of brain development is a major aim in the Neonatal Intensive Care Unit. Hypoxic-Ischemic Encephalopathy (HIE) occurs in 3-5 per 1000 births. Only 47% of neonates have normal outcomes. The neurodevelopmental consequences of brain injury for asphyxiated term infants include cerebral palsy, severe intellectual disabilities and also a number of minor behavioural and cognitive deficits. However, there are very few therapeutic strategies for the prevention or treatment of brain damage. The gold standard is hypothermic treatment but, according to the literature, melatonin potentially acts in synergy with hypothermia for neuroprotection and to improve neurologic outcomes. Melatonin appears to be a good candidate because of its different protective effects including reactive oxygen species scavenging, excitotoxic cascade blockade, modulation of neuroinflammatory pathways. The research study will evaluate the neuroprotective properties and the effects of Melatonin in association with therapeutic hypothermia for hypoxic ischemic encephalopathy.

NCT ID: NCT03802175 Recruiting - Hypoxemia Clinical Trials

The Application Of Lung Ultrasound In Postoperative Hypoxemia Patients

Start date: January 10, 2019
Phase:
Study type: Observational [Patient Registry]

Postoperative hypoxemia was persistent and common after surgery.Rapid diagnosis and subsequent therapeutic measures must be adopted by anesthesiologists.Lung ultrasound has been confirmed to be more sensitive and accurate for diagnosis of pulmonary ailment than chest radiography.The primary objective of the present study was to evaluate lung complications by bedside lung ultrasonography on patients suffered from hypoxemia after general anesthesia in the postoperative period.

NCT ID: NCT03797482 Recruiting - Clinical trials for Breast Cancer Female

A Prospective Evaluation of the Peri-operative Hypoxia in Breast Cancer

Hypoxia
Start date: November 27, 2017
Phase:
Study type: Observational

To understand the effects induced by acute hypoxia that sets in during surgery in breast cancer. To study this, clinical samples (Tumor biopsies) will be obtained during the surgery after partial devascularisation (sample B) and stored for future genomic and proteonomic evaluations.